Cargando…
Anti-C1q Autoantibodies, Novel Tests, and Clinical Consequences
Although anti-C1q autoantibodies have been described more than four decades ago a constant stream of papers describing clinical associations or functional consequences highlights that anti-C1q antibodies are still hot and happening. By far the largest set of studies focus on anti-C1q antibodies is s...
Autores principales: | Mahler, Michael, van Schaarenburg, Rosanne A., Trouw, Leendert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3653116/ https://www.ncbi.nlm.nih.gov/pubmed/23717311 http://dx.doi.org/10.3389/fimmu.2013.00117 |
Ejemplares similares
-
C1q Deficiency and Neuropsychiatric Systemic Lupus Erythematosus
por: van Schaarenburg, Rosanne A., et al.
Publicado: (2016) -
Circulating Levels of Anti-C1q and Anti-Factor H Autoantibodies and Their Targets in Normal Pregnancy and Preeclampsia
por: Dijkstra, Douwe Jan, et al.
Publicado: (2022) -
Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus
por: Kleer, Jessica S., et al.
Publicado: (2022) -
A longitudinal study of C1q and anti-C1q autoantibodies in homologous and heterologous pregnancies for predicting pre-eclampsia
por: Agostinis, Chiara, et al.
Publicado: (2022) -
Autoantibodies Against C3b—Functional Consequences and Disease Relevance
por: Vasilev, Vasil V., et al.
Publicado: (2019)